How it works
Get started by filling out the online enrollment application to find out if you are eligible for assistance.
NiceRx verifies your eligibility for medication assistance and notifies you if you are pre-qualified. The pharmaceutical company provides your medication for free, and you only pay our service fee.
We will request documents to be submitted by you and your healthcare provider that are required by the pharmaceutical company to complete your enrollment.
Once approved, the pharmaceutical company typically ships a 90-day supply of medication to your home or healthcare provider’s address. Final acceptance is determined by the pharmaceutical company.
Your monthly Cablivi cost savings if eligible
With our assistance, you could access the Cablivi patient assistance program and obtain your medication for free. We only charge a flat monthly fee of $49 per medication for our services.
Am I eligible for Cablivi patient assistance?
We review each Cablivi enrollment application individually to determine if you are eligible. Each assistance program has its own eligibility criteria and the factors considered by most programs are:
- I am a permanent, legal resident of the United States or Puerto Rico
- I am uninsured or my insurance doesn’t cover my medication
- I meet certain income eligibility requirements
How do I apply for the Cablivi patient assistance program?
Our process makes it as easy as possible to apply for the Cablivi patient assistance program. Begin by completing the enrollment application form on our website. Tell us about any medications that you are taking, including Cablivi, your healthcare provider, your insurance plan, and your household income. This information is required by the pharmaceutical manufacturers who will supply the medication, so it is important to make sure this information is accurate and up to date.
We will review the information that you have provided to determine whether you are eligible for patient assistance. If we can pre-qualify you for assistance, NiceRx will handle the full enrollment process on your behalf. If you are approved by the pharmaceutical company, you will typically start receiving your medication in 6 – 8 weeks.
Is NiceRx a Cablivi coupons provider?
NiceRx is not a Cablivi coupon, Cablivi discount card, or Cablivi copay card provider. We do not offer Cablivi manufacturer coupons, Cablivi discounts, rebates, Cablivi savings cards, trial offers, or free Cablivi samples. We are a service provider that helps eligible individuals access their medication directly from the U.S. pharmaceutical company.
Can NiceRx help me if I have insurance?
NiceRx may be able to help you if:
- You have a high copay or coinsurance responsibility for Cablivi
- Your insurance company will not pay for your Cablivi prescription
- Your healthcare plan does not cover your medication
- You do not have insurance
Please apply online to find out if we can help you.
How much does Cablivi cost without insurance?
Without insurance, Cablivi costs will vary depending on where you buy the medication as prices will vary by retailer. As a guide, Cablivi injectable kits 11 mg will cost around $7,630 for 1 kit.
How much does Cablivi cost with insurance?
The copay for Cablivi will depend on the terms of your healthcare plan. Your healthcare provider or pharmacist will be able to calculate your copay with your current insurance. Contact them to find out more.
What is Cablivi?
Cablivi is an FDA (U.S. Food and Drug Administration) approved medication manufactured by Ablynx N.V., Belgium, a Sanofi company. It is a von Willebrand factor (vWF)-directed antibody fragment used for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP), in combination with plasma exchange and immunosuppressive therapy.
Acquired thrombotic thrombocytopenic purpura (aTTP) is a rare, life-threatening blood clotting disorder. During an episode of aTTP, clots form throughout the body, leading to low platelet counts, destroying red blood cells, and causing damage to organs (especially the brain and heart).
What doses of Cablivi are available?
Cablivi is available in injection form, in the following doses: 11 mg as a lyophilized powder in a single-dose vial.
First day of treatment – 11 mg bolus intravenous injection at least 15 minutes before plasma exchange followed by an 11 mg subcutaneous injection after completion of plasma exchange. Subsequent treatment during daily plasma exchange: 11 mg subcutaneous injection once daily following plasma exchange.
Treatment after the plasma exchange period: 11 mg subcutaneous injection once daily for 30 days beyond the last plasma exchange. If after the initial treatment course, sign(s) of persistent underlying disease such as suppressed ADAMTS13 activity levels remain present, treatment may be extended for a maximum of 28 days. Discontinue treatment if the patient experiences more than 2 recurrences of aTTP, while on Cablivi.
Clean the injection site before administering the injection with rubbing alcohol and change the injection site each time to reduce injury under the skin.
Store Cablivi in its original carton in the refrigerator. You may store an unopened Cablivi carton at room temperature for up to 2 months. Do not return it to the refrigerator once the medicine has reached room temperature. Only use the needle and syringe once and then place in a puncture-proof “sharps” container.
Please see full prescribing information and always speak with a healthcare professional about any changes to your dose so they can monitor and evaluate your condition.
Cablivi active ingredients
The active ingredient of Cablivi is caplacizumab. Its mechanism of action is to target the A1-domain of vWF and block the interaction between vWF and platelets, reducing both vWF-mediated platelet adhesion and platelet consumption.
Cablivi side effects
The most common side effects (incidence >15%) of Cablivi in clinical trials compared to placebo include:
- Epistaxis (nosebleeds)
- Gingival bleeding (bleeding gums)
In rare instances, Cablivi can cause more serious adverse reactions. These can include:
- Severe bleeding – risk is increased in patients with underlying coagulopathies. If excessive bleeding or bruising occurs, interrupt treatment. Withhold for 7 days before elective surgery, dental procedures, or other invasive interventions
Your doctor will assess the benefits of using Cablivi against your risk of side effects. Patients are encouraged to report negative side effects or adverse reactions of Cablivi to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Cablivi drug interactions
Cablivi can interact with other medications. These include:
- Anticoagulants – may increase the risk of bleeding
This list is not exhaustive and other prescription drugs may interact with Cablivi.
You should not use Cablivi if you:
- Are allergic to the active ingredient caplacizumab
- Are allergic to any of the other ingredients in Cablivi
Talk to your doctor before using Cablivi if you:
- Are taking any of the medications that could interact with Cablivi
- Are pregnant or are planning to become pregnant
- Are breastfeeding or are planning to breastfeed
- Have a bleeding or blood clotting disorder such as hemophilia – due to a potential increased risk of bleeding, treatment in patients with severe hepatic impairment requires close monitoring
Cablivi is the trademark brand name for caplacizumab manufactured by Ablynx NV. a Sanofi company. A generic version of caplacizumab is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Cablivi savings through NiceRx.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.